Methylfolate (5-MTHF) bypasses the genetic bottleneck caused by MTHFR variants—carried by up to 40% of the population—that impair conversion of synthetic folic acid, outperforming #7 Zinc Picolinate in genetic compatibility. This active form directly supports DNA repair, neurotransmitter synthesis, and homocysteine metabolism, preventing 70% of neural tube defects when taken periconceptionally. With 50% higher bioavailability than folic acid, it is essential for women of childbearing age and anyone with methylation impairments.

Comments on "Folate (Methylfolate, 5-MTHF)"
Create a free account or sign in to join the discussion.
Sign in to join the conversation